Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial
帕博利珠单抗联合新辅助化疗对早期乳腺癌女性病理完全缓解的影响：正在进行的 II 期适应性随机 I-SPY2 试验的分析
期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2019.6650
Nanda, Rita; Liu, Minetta C; Yau, Christina; Shatsky, Rebecca; Pusztai, Lajos; Wallace, Anne; Chien, A Jo; Forero-Torres, Andres; Ellis, Erin; Han, Heather; Clark, Amy; Albain, Kathy; Boughey, Judy C; Jaskowiak, Nora T; Elias, Anthony; Isaacs, Claudine; Kemmer, Kathleen; Helsten, Teresa; Majure, Melanie; Stringer-Reasor, Erica; Parker, Catherine; Lee, Marie C; Haddad, Tufia; Cohen, Ronald N; Asare, Smita; Wilson, Amy; Hirst, Gillian L; Singhrao, Ruby; Steeg, Katherine; Asare, Adam; Matthews, Jeffrey B; Berry, Scott; Sanil, Ashish; Schwab, Richard; Symmans, W Fraser; van 't Veer, Laura; Yee, Douglas; DeMichele, Angela; Hylton, Nola M; Melisko, Michelle; Perlmutter, Jane; Rugo, Hope S; Berry, Donald A; Esserman, Laura J
